Impact of Real-World Evidence on Payers & Patients

November 24, 2020

Dr. Scott Gottlieb, Former Commissioner of the Food and Drug Administration speaks with Parexel’s Peyton Howell, Executive Vice President, Chief Commercial & Strategy Officer and Sy Pretorius, Executive Vice President, Chief Medical & Scientific Officer about the evolving role of RWE.

Previous Video
Parexel on the pulse
Parexel on the pulse

Parexel regulatory expert, Mark Birse, gives an update on BREXIT.

Next Video
Real-World Evidence: The Feedback Loop
Real-World Evidence: The Feedback Loop

RWE experts Leanne Larson, Senior Vice President and Worldwide Head, Real-World Evidence and Access and Amy...